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TO THE EDITORDo Advances in
Technology in the
Catheterization
Laboratory for
Percutaneous Coronary
Interventions Negatively
Inﬂuence an Operator’s
Technique, Decision
Making, and Judgment?Interventional procedures performed in the early
years of percutaneous coronary intervention (PCI)
required an adequate technique as well as excellent
clinical judgment. We learned all too frequently
about complications, and sometimes through trial
and error, these could be adequately managed
without the need for emergent coronary artery bypass
graft (CABG). Despite this, the procedures were often
unpredictable, and CABG rates were as high as 4% to
6%. Of course, stenting changed the way in which
procedures were performed and vastly improved
outcomes. Most procedures also became technically
easier, and over the years, the combination of
appropriate antithrombotic/anticoagulant therapy
with better and slicker equipment revolutionized
outcomes and increased access to more complex
cases while reducing complications.
However, there is a potential Yin/Yang to these
improvements. The easier the procedure becomes for
routine cases, there is a possibility that there will be,
particularly for the recently trained interventionalist,
both poorer technique and inappropriate interven-
tional judgment compared with those trained in the
past. (It should be mentioned that a routine case for
me does not include chronic total occlusions or
complex 3 vessel, left main, or some complex bifur-
cation interventions.) The daily decisions that inter-
ventionalists face such as when to end or abort a
procedure or when not to even consider undertaking
the intervention may never be adequately under-
stood. Also, the ability to react to complications(as infrequent as they have become) might also suffer.
The novice becomes desensitized and complacent
and might be unfamiliar with how to appropriately
manage them. The relative ease of stent deployment
and the appearance of an apparently favorable
angiographic result may also impair decision making
as to the use of appropriate adjunctive technology.
One example is the use of intravascular ultrasound to
guide stent deployment. Although the data suggest it
to be appropriate (1,2), it is used in only a minority of
cases (3). The same can be said for fractional ﬂow
reserve in the evaluation of moderate lesions.
According to the National Cardiovascular Data Reg-
istry, this technique was used in <10% (4).
This potential disequilibrium between technolog-
ical advances and individual ability and judgment
and decision making is also apparent in other disci-
plines of cardiology as well as other tech-driven
professions. The routine use of echocardiographic
imaging has made the stethoscope nearly obsolete.
I am now appalled by the inability of most fellows to
diagnose the most basic of cardiac murmurs with a
stethoscope unless the echocardiogram/Doppler pro-
vides the answer. Technology is also driving the
physician away from direct patient contact. Symp-
tomatic coronary disease management is still highly
dependent on the history, which is, in my opinion,
not always accurately obtained, in part as a result of
relying on technology for answers.
In the airline industry, pilots must train long hours
to retain the skills necessary to manually land
airplanes in the face of advanced automation. Auto-
mobile manufacturers boast of a car’s ability to park,
steer, and brake with little input from the driver.
These advances should improve safety but at the
potential cost of negatively affecting an operator’s
skill level. Another example is the negative impact
of television and computers on our children and
grandchildren’s overall physical conditioning and
health.
Returning to the interventional laboratory, are
there potential solutions? Randomized trials, regis-
tries, and appropriateness guidelines provide an
excellent framework concerning the best practices
available. Minimal yearly volume requirements
attempt to ensure that the operator is busy enough to
retain an appropriate skill level, although the mini-
mal number has recently been reduced from 75 to
50 cases per year (5). These are not sufﬁcient, in my
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1199opinion, to overcome the downsides associated with
technological advances as they do not directly
address all potential issues of technique, judgment,
and decision making in the individual patient.
According to the Accreditation Council for Graduate
Medical Education, the minimal requirement for
interventional training today is to perform 250 coro-
nary procedures per year as the primary operator.
I personally doubt whether this number is sufﬁcient,
given all the nuances in treating sick, complex pa-
tients, particularly in the acute setting.
Even if minimal numbers were increased (there is
not one number that ﬁts all), it is essential that the
young interventionalist in training uses all available
tools. I believe that this should be mandatory. These
would include training with hands-on simulation
programs and review and live demonstration semi-
nars, all of which are given by interventional societies
such as the Society for Cardiac Angiography and
Intervention. Most importantly, all fellows ﬁnishing
training should seek the help of a seasoned, experi-
enced interventionalist whenever feasible who
can provide input in all cases for an indeﬁnite period
of time. Those of us with this experience should
make ourselves available. Finally, all of us should
strive to review, whenever possible, all complex cases,
particularly if not emergent, before the percuta-
neous coronary intervention procedure with other
interventionalists and, when appropriate, cardiac
surgeons.
Interventional cardiology is an art as well as a
science. In other disciplines, apprenticeships last for
several years. Although it is not practical to spend
additional years in training, learning is a lifelong
journey. I believe that we owe this to the patient and
to our profession. If nothing else, I hope that this
point of view will generate discussion among our
colleagues.*John A. Ambrose, MD
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Prediction of
Hyperglycemia at
Coronary AngiographyPeriprocedural hyperglycemia is a potentially re-
versible cause of poor outcomes in patients with
diabetes mellitus (DM) undergoing percutaneous
coronary intervention (PCI) (1,2). However, simple
preventive strategies such as continuing long-acting
glucose-lowering medications are not routinely
implemented due to concern for hypoglycemia (3).
We recently demonstrated the efﬁcacy of continuing
rather than holding long-acting glucose-lowering
medications in patients with DM undergoing coronary
angiography with possible PCI (4). In this study, we
sought to develop a risk score to predict hyperglyce-
mia at the time of coronary angiography in patients
with DM to help target a high-risk group of patients
for whom the beneﬁts of treatment may outweigh the
risks of hypoglycemia.
In the periprocedural glycemic control trial at the
Manhattan Veterans Affairs Hospital, patients with
DM were randomized to continue or hold long-acting
glucose-lowering medications before coronary angi-
ography (4). The hold group (n ¼ 86) serves as the
development cohort, and details regarding this cohort
were previously described (4).
Patients undergoing PCI between November 2010
and February 2012 participated in a prospective reg-
istry at the New York University Langone Medical
Center. Those with pharmacologically treated DM and
recorded blood glucose at the time of the procedure
(n ¼ 168) served as the validation cohort. A nurse
educator provided telephone instructions to hold
glucose-lowering medications before the procedure
during this time per routine care. Although variables
of interest in the validation cohort were prospectively
collected, fasting time and periprocedural glucose
were collected by retrospective review of the elec-
tronic procedural charts.
